May 2026 Mölnlycke Health Care and Zhende Medical formed a joint venture in China to combine their advanced wound care portfolios, expanding commercial access to surgical dressings and advanced wound management products across hospitals, pharmacies, and e-commerce channels.
May 2026 Kreate Medical received U.S. FDA 510(k) clearance for its Antibacterial Absorbable Synthetic Matrix and Absorbable Synthetic Matrix, expanding its surgical dressing portfolio with advanced wound management products for the U.S. market.
November 2025 Solventum signed a definitive agreement to acquire Acera Surgical for up to USD 850 million, expanding its MedSurg portfolio with synthetic regenerative tissue matrices and strengthening its advanced surgical wound care and dressing solutions.
May 2025 Summit Products Group entered into a strategic partnership with NovaBone Products to exclusively distribute NovaForm® Wound Matrix in the U.S., expanding access to FDA-cleared advanced surgical and wound dressing solutions for acute and chronic wound care.